SUBSCRIBE
SUBSCRIBE
News   Policy

MedWatch: Update of Safety Review for Vytorin, Zetia, and Zocor

January 9, 2009 | 
1 min read
The FDA has completed its review of the final clinical study report of ENHANCE and issued an update. Read the MedWatch safety summary, including links to the January 2008 FDA Early Communication and the January 2009 Update.
Regulatory
Merck & Co.
MORE ON THIS TOPIC
Podcast
Vertex carries M&A uptick into H2, IPOs and VC raises also grow, FDA on pace despite turmoil
July 8, 2026
 · 
1 min read
 · 
Jef Akst
Digital scanning effect of human kidneys glowing in blue, highlighting intricate details with a futuristic design. The image emphasizes respiratory system anatomy and health.
Approvals
Vera moves into growing kidney disease space with FDA’s accelerated IgAN nod
July 7, 2026
 · 
2 min read
 · 
Annalee Armstrong
Creative photo collage geometry figures scales platform weight hands body fragments pointing finger stability spheres measure.
FDA
Despite chaos and churn, FDA decisions hold mostly steady in H1 2026
July 6, 2026
 · 
8 min read
 · 
Tristan Manalac
Editorial
Biotech’s China problem: An issue of national security or economic value for the US?
July 2, 2026
 · 
6 min read
 · 
Jef Akst